Search Results
Resources
Maintaining Viable Cell Count in Primary T Cells During Cell Washing Using Optibumin®
Reducing Serum-Associated Contaminants from Growth Media in Primary Cell Culture
SARS-CoV2 and Influenza – Double Threat
InVitria’s Top Insights from ISCT 2018 – Montreal
ECI Conference 2019: The Latest Innovations and Trends in Cell & Gene Therapy
T Cell Cryopreservation Using Exbumin®, Recombinant Human Serum Albumin, and Reduced DMSO
Cellastim S – Reconstitution Application Note
Recombinant Human Leukemia Inhibitory Factor for the Enhanced Expansion of Neural Stem Cells
Emergence of Blood-Free Recombinant Human Albumin
Controlling Impurities in Cell Culture Media
OptiVERO – Expansion of VERO Cells Without Serum in Chemically Defined Cell Culture Media
Optibumin vs Traditional Albumin: Comparing Performance in Cell Wash Applications
Scaling Innovation: How DiscGenics and InVitria are Leading the Future of Cell Therapy
Solving the Vaccine Supply Challenge
Using Recombinant Transferrin in the Expansion of Hematopoietic Stem Cells Application Note
Products
Lacromin® – Recombinant human holo-lactoferrin
Exbumin® – Recombinant human albumin excipient
ITSE + A™ – Blood-free cell culture media supplement
ITS AF™ – Blood-free cell culture media supplement
ITSE Animal-Free® – Blood-free cell culture media supplement
Cellastim S® – Recombinant human albumin
Optibumin ® 20 – Recombinant human albumin
Optibumin ® 25 – Recombinant human albumin
Optiferrin® – Recombinant human transferrin
Lysobac® – Recombinant human lysozyme